×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
IRMD – iradimed corporation (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
IRMD
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
2/14
01:28 pm
irmd
Iradimed Corporation (NASDAQ: IRMD) had its "buy" rating re-affirmed by analysts at Roth Mkm. They now have a $72.00 price target on the stock, up previously from $60.00.
Low
Report
Iradimed Corporation (NASDAQ: IRMD) had its "buy" rating re-affirmed by analysts at Roth Mkm. They now have a $72.00 price target on the stock, up previously from $60.00.
2/13
07:07 pm
irmd
IRadimed (IRMD) Lags Q4 Earnings Estimates [Yahoo! Finance]
Low
Report
IRadimed (IRMD) Lags Q4 Earnings Estimates [Yahoo! Finance]
2/13
09:40 am
irmd
IRADIMED CORPORATION Announces Fourth Quarter and Full Year of 2024 Financial Results and Increases its Regular Quarterly Cash Dividend to $0.17 Per Share from $0.15 Per Share [Yahoo! Finance]
Medium
Report
IRADIMED CORPORATION Announces Fourth Quarter and Full Year of 2024 Financial Results and Increases its Regular Quarterly Cash Dividend to $0.17 Per Share from $0.15 Per Share [Yahoo! Finance]
2/13
08:30 am
irmd
IRADIMED CORPORATION Announces Fourth Quarter and Full Year of 2024 Financial Results and Increases its Regular Quarterly Cash Dividend to $0.17 Per Share from $0.15 Per Share
Medium
Report
IRADIMED CORPORATION Announces Fourth Quarter and Full Year of 2024 Financial Results and Increases its Regular Quarterly Cash Dividend to $0.17 Per Share from $0.15 Per Share
2/13
01:58 am
irmd
Iradimed Corporation (NASDAQ: IRMD) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
High
Report
Iradimed Corporation (NASDAQ: IRMD) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
2/5
02:34 am
irmd
Iradimed Corporation (NASDAQ: IRMD) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Low
Report
Iradimed Corporation (NASDAQ: IRMD) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
1/30
08:30 am
irmd
IRADIMED CORPORATION to Hold Fourth Quarter of 2024, Full Year of 2024 Financial Results Conference Call on February 13, 2025
Low
Report
IRADIMED CORPORATION to Hold Fourth Quarter of 2024, Full Year of 2024 Financial Results Conference Call on February 13, 2025
1/28
11:06 pm
irmd
Iradimed Corporation (NASDAQ: IRMD) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Low
Report
Iradimed Corporation (NASDAQ: IRMD) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
2/13
01:29 pm
irmd
Form SCHEDULE 13G IRADIMED CORP Filed by: Nine Ten Capital Management LLC
Low
Report
Form SCHEDULE 13G IRADIMED CORP Filed by: Nine Ten Capital Management LLC
2/13
08:30 am
irmd
Form 8-K IRADIMED CORP For: Feb 13
Medium
Report
Form 8-K IRADIMED CORP For: Feb 13
1/10
12:15 pm
irmd
Form 8-K IRADIMED CORP For: Jan 10
Low
Report
Form 8-K IRADIMED CORP For: Jan 10
1/6
04:07 pm
irmd
Form 144 IRADIMED CORP Filed by: GLENN JOHN
Low
Report
Form 144 IRADIMED CORP Filed by: GLENN JOHN
12/13
04:00 pm
irmd
Form 4 IRADIMED CORP For: Dec 11 Filed by: ALLEN MONTY K
Low
Report
Form 4 IRADIMED CORP For: Dec 11 Filed by: ALLEN MONTY K
12/13
04:00 pm
irmd
Form 4 IRADIMED CORP For: Dec 11 Filed by: Chiprin Jeff
Low
Report
Form 4 IRADIMED CORP For: Dec 11 Filed by: Chiprin Jeff
12/13
04:00 pm
irmd
Form 4 IRADIMED CORP For: Dec 11 Filed by: VUOTO ANTHONY
Low
Report
Form 4 IRADIMED CORP For: Dec 11 Filed by: VUOTO ANTHONY
12/13
04:00 pm
irmd
Form 4 IRADIMED CORP For: Dec 11 Filed by: Scharen-Guivel Hilda Frederique
Low
Report
Form 4 IRADIMED CORP For: Dec 11 Filed by: Scharen-Guivel Hilda Frederique
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
7/29
Form 8-K IRADIMED CORP For: Jul 29
33.3%
9/12 Form 4 IRADIMED CORP For: Sep 10 Filed by: JOHNSON BRENT 13.4%
3/24 Iradimed Corp (NASDAQ: IRMD) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $18.00 price target on the stock. 12.5%
3/31 Iradimed Corp (NASDAQ: IRMD) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $21.00 price target on the stock. 9.7%
12/11 Form 4 IRADIMED CORP For: Dec 09 Filed by: JOHNSON BRENT 7.7%
2/6 IRADIMED CORPORATION Announces Fourth Quarter 2019 Financial Results 7.1%
4/3 Iradimed Corp (NASDAQ: IRMD) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. 6.9%
10/30 Q3/2019 9/30/2019 EPS 0.230 ZacksConsensus 0.130 ActVsEst 0.100 - Beat 5.7%
4/14 Iradimed Corp (NASDAQ: IRMD) had its price target lowered by analysts at Roth Capital from $32.00 to $30.00. 5.0%
8/7 Form 4 IRADIMED CORP For: Aug 05 Filed by: JOHNSON BRENT 4.9%
9/12 Form 4 IRADIMED CORP For: Sep 10 Filed by: JOHNSON BRENT 13.4%
3/24 Iradimed Corp (NASDAQ: IRMD) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $18.00 price target on the stock. 12.5%
3/31 Iradimed Corp (NASDAQ: IRMD) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $21.00 price target on the stock. 9.7%
12/11 Form 4 IRADIMED CORP For: Dec 09 Filed by: JOHNSON BRENT 7.7%
2/6 IRADIMED CORPORATION Announces Fourth Quarter 2019 Financial Results 7.1%
4/3 Iradimed Corp (NASDAQ: IRMD) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. 6.9%
10/30 Q3/2019 9/30/2019 EPS 0.230 ZacksConsensus 0.130 ActVsEst 0.100 - Beat 5.7%
4/14 Iradimed Corp (NASDAQ: IRMD) had its price target lowered by analysts at Roth Capital from $32.00 to $30.00. 5.0%
8/7 Form 4 IRADIMED CORP For: Aug 05 Filed by: JOHNSON BRENT 4.9%
TOP News Decliners
4/30
Form 8-K IRADIMED CORP For: Apr 30
-9.0%
3/12 IRADIMED CORPORATION Announces the Appointment of Lynn Neuhardt as Vice President of Research and Development -7.8%
5/7 Iradimed Corp (NASDAQ: IRMD) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $28.00 price target on the stock. -6.1%
11/1 Iradimed Corp (NASDAQ: IRMD) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. -5.8%
2/25 Form 4 IRADIMED CORP For: Feb 24 Filed by: JOHNSON BRENT -5.6%
2/28 Iradimed Corp (NASDAQ: IRMD) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. -5.1%
8/5 Form 4 IRADIMED CORP For: Aug 01 Filed by: Waldman Louis S. -5.1%
11/5 Form 4 IRADIMED CORP For: Nov 04 Filed by: Nardi Steven M. -4.9%
3/26 Form 4 IRADIMED CORP For: Mar 24 Filed by: JOHNSON BRENT -4.5%
3/4 Form 4 IRADIMED CORP For: Mar 02 Filed by: JOHNSON BRENT -3.9%
3/12 IRADIMED CORPORATION Announces the Appointment of Lynn Neuhardt as Vice President of Research and Development -7.8%
5/7 Iradimed Corp (NASDAQ: IRMD) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $28.00 price target on the stock. -6.1%
11/1 Iradimed Corp (NASDAQ: IRMD) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. -5.8%
2/25 Form 4 IRADIMED CORP For: Feb 24 Filed by: JOHNSON BRENT -5.6%
2/28 Iradimed Corp (NASDAQ: IRMD) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. -5.1%
8/5 Form 4 IRADIMED CORP For: Aug 01 Filed by: Waldman Louis S. -5.1%
11/5 Form 4 IRADIMED CORP For: Nov 04 Filed by: Nardi Steven M. -4.9%
3/26 Form 4 IRADIMED CORP For: Mar 24 Filed by: JOHNSON BRENT -4.5%
3/4 Form 4 IRADIMED CORP For: Mar 02 Filed by: JOHNSON BRENT -3.9%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: